πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 677 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7378403

Akt inhibitors, pharmaceutical compositions, and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378093

Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus select

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378276

Method of inducing memory B cell development and terminal differentiation

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378277

Methods and compositions for transforming dendritic cells and activating T cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7374872

CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7375185

Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7374756

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7371392

Cd40 ligand adjuvant for respiratory syncytial virus

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7371572

Mouse titers after two immunizations with VLPs alone

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368116

Method of enhancing a targeted immune response against tumors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368106

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368110

Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368114

Fusion protein including of CD4

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7364719

Vasoregulating compounds and methods of their use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7361664

Vitamin D receptor antagonists and related compositions and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7361356

Self-assembling recombinant papillomavirus capsid proteins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7338807

Screening assays for compounds that cause apoptosis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7339037

Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, v

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7335749

Tumor suppressor gene, p47Ing3

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7332590

Molecular characteristics of non-small cell lung cancer

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7332645

IL-21 as a regulator of immunoglobin production

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7330748

Method for determining in vivo concentration of a metabolite

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7329502

ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7314631

Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect agains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted